A few days ago，China Medical Business Association United Nations Medicine Holdings、Kyushu Tong、China Resources Medicine、Harbin Pharmaceutical Group and other 9 pharmaceutical circulation enterprises set up temperature -sensitive drug circulation safety laboratory (hereinafter referred to as & ldquo; laboratory & rdquo;)，and plan to formulate a medical cold chain standard stake online sports bettingfor stake betting app3 years。According to the plan，This laboratory will start from 2014，Enter the test stage，1 year，2015 is the standard formulation and verification stage，Achievement appraisal will be completed in the first half of 2016。

    In recent years，The State Food and Drug Administration and the Ministry of Health and other relevant departments have been soliciting opinions for the revision of the new version of the "Specifications for the Management of Drug Business" (GSP)。At the end of 2012，"Cold Chain Logistics Classification and Basic Requirements"、The two national standards of the "Code of Drug Cold Chain Logistics Operation" have been introduced one after another。The new version of GSP, which was officially implemented on June 1 this year, also emphasized the management and improvement of stake betting appthe cold chain of medicine。Some analysts prediction，until 2014，Medicine Cold Chain market value will increase by 10%each year. China Medical Cold Chain, which was originally & ldquo;、Small、Chaos、Weak & rdquo; The market will be able to reshuffle，At the same time of the challenge coming，It will also bring more business opportunities and progress。

    The reality is，Currently medical logistics is not cold chain transport。It is understood，The investment My stake betting appin stake betting appthe cold chain of medicine is generally higher，Many drug circulation companies in order to maximize profits，Naturally unwilling to use a cold chain system with a very high cost。As far as developed countries are concerned，Medical circulation enterprises must ensure more than 25%gross profit margin to maintain healthy development，At present, the gross profit margin of my country's medical circulation enterprises is generally less than 10%，Low the industry profits are even more competitive and disorderly。& ldquo; In this case，Some large pharmaceutical production companies prefer to spend high cost self -built logistics centers，I don’t want to adopt a third -party logistics method。& rdquo; The above analysts said。

    The reporter interviewed several listed pharmaceutical companies involved in the construction of this laboratory yesterday，Among them, Kyushu Tong、Shanghai Medicine、China Resources Medicine、Harbin Pharmaceuticals and other medical circulation leaders have established their own medical cold chain system。Harbin Pharmaceutical said，The company has a dedicated medical logistics company，and the biological engineering company set up by the group due to the delivery of blood products、Demand for special medicines such as vaccine，stake betting appstake online sports bettingIt also has its own cold chain logistics system，To ensure the quality of the drug during the delivery process。People from Shanghai Medical Securities Department told reporters: & ldquo; The company conducts its own medical distribution business with Shanghai Medical Dipping Holdings as its core，And to form a national distribution network through the group's more than 40 subsidiaries and more than 30 logistics centers。Cold Chain Logistics is a very important part of the company's setting for biological product distribution。& rdquo;

    For the strategy of cooperating with the China Medical Business Association to jointly study the cold chain of the pharmaceutical medicine，The person in charge of the Kyushu Pharmaceutical Distribution Department told reporters: & ldquo; The company already had its own logistics distribution platform，and the corresponding cold chain system。After the laboratory was established，The company mainly undertakes the inspection work of the cold chain logistics environment and equipment，It will not have a big impact on the company's logistics business in the short term。We aim to formulate a more perfect formulation for the entire medical cold chain industry、Powerful industry standards。& rdquo;